causal
Industry judging its own products is structurally flawed
Asking pharmaceutical and device companies to fund and effectively judge the products they produce—analogous to credit-rating agencies paid by bond issuers before the 2008 financial crisis—creates a structural conflict of interest where reviewers and consumers of data must constantly tease out whether industry has 'pulled something over' through patient selection and study design.
causalpending
Speaker
Adam CifuEvidence Quote
“we are really asking industry, to a great extent, to judge the products that they are producing”
Created: 6/13/2026, 12:18:13 AM
Your notes
Loading notes...